Department of Chemistry, Chung Yuan Christian University, Chung Li, Taiwan.
Taiwan J Obstet Gynecol. 2012 Dec;51(4):515-25. doi: 10.1016/j.tjog.2012.09.005.
Alzheimer disease (AD) is by far the most common cause of dementia globally. This neurodegenerative disorder of the brain is chronic and progressive, characterized clinically by the deterioration in the key symptoms of behavioral and cognitive abilities. Treatment options for this disease currently are limited. Deposition of amyloid-β and tau hyperphosphorylation are cardinal pathologic features of AD that lead to the formation of neuronal plaques and neurofibrillary tangles, respectively. In addition to mounting research on herbal compounds for the treatment of AD, curcuminoids and resveratrol appear to be beneficial as anti-AD agents. Curcuminoids (curcumin and demethoxycurcumin) and resveratrol possess unique properties that make them especially worthy of further studies. This review article revisits and presents the current research done on the potential of the curcuminoids curcumin and demethoxycurcumin and the polyphenolic compound resveratrol as anti-AD compounds.
阿尔茨海默病(AD)是目前全球最常见的痴呆症病因。这种大脑神经退行性疾病是慢性进行性的,临床上以行为和认知能力的关键症状恶化为特征。目前,这种疾病的治疗选择非常有限。淀粉样蛋白-β和 tau 过度磷酸化的沉积是 AD 的主要病理特征,分别导致神经元斑块和神经原纤维缠结的形成。除了对治疗 AD 的草药化合物进行大量研究外,姜黄素和白藜芦醇似乎作为抗 AD 药物是有益的。姜黄素类(姜黄素和去甲氧基姜黄素)和白藜芦醇具有独特的特性,使它们特别值得进一步研究。本文回顾并介绍了姜黄素类姜黄素和去甲氧基姜黄素以及多酚化合物白藜芦醇作为抗 AD 化合物的潜在研究进展。